The FDA is considering lifting restrictions for off-label drug promotion

February 16, 2008

Matthew Mintz and Merrill Goozner comment on the implications of this.



Related posts:

  1. Is fibromyalgia real, and if so, are drug companies profiting from the uncertainty of the disease?
  2. Should you stop taking Vytorin if you’re already on the drug?
  3. Did Medscape use CME to illegally promote off-label use of drugs for rheumatoid arthritis?
  4. CT scans and lung cancer screening redux
  5. Who’s to blame for overutilization?
  6. Pharmacies in bed with drug companies?
  7. The Medicare cuts


KevinMD.com on Facebook


  Follow on Twitter   Subscribe



Comments on this entry are closed.

Previous post: Stop pinching the hospitals?

Next post: Sobriety

Site Meter